3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
49.95
+0.10 (0.20%)
Sep 19, 2025, 3:00 PM CST
0.20%
Market Cap3.89B
Revenue (ttm)324.87M
Net Income (ttm)133.88M
Shares Out77.84M
EPS (ttm)1.71
PE Ratio29.25
Forward PEn/a
Dividend0.53 (1.06%)
Ex-Dividend DateJul 7, 2025
Volume218,841
Average Volume322,764
Open49.85
Previous Close49.85
Day's Range49.40 - 50.10
52-Week Range34.85 - 73.50
Beta0.33
RSI55.42
Earnings DateNov 13, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.